New CLL Meds: Improved Survival Rates, 1990–2018
While cutting-edge treatments such as CAR T-cell therapies, clinical trials, and costly transplants for chronic lymphocytic leukemia (CLL) are not ...
While cutting-edge treatments such as CAR T-cell therapies, clinical trials, and costly transplants for chronic lymphocytic leukemia (CLL) are not ...
CHICAGO — New results in the treatment of advanced ovarian cancer have been welcomed by an expert not involved in ...
The phenolic compound intake (PCI) of traditional Mexican food positively affects health conditions and supports the hypothesis that specific nutritional foods ...
The results from a prognostic genomic assay called HER2DX convinced a group of Spanish oncologists to change treatment plans for ...
While they're much less likely to develop chronic lymphocytic leukemia (CLL) than are White patients, African-American patients with this blood ...
Tarek Mouhieddine, MD, grew up as a child of war-torn Lebanon. Now building his career as a New York–based hematologist ...
(Reuters) -Merck & Co Inc and Eisai Co Ltd said on Friday they were discontinuing a late-stage study of Keytruda ...
Some patients with HER2-positive breast cancer can reduce the intensity of adjuvant chemotherapy while maintaining the full benefits in terms ...
NEW ORLEANS — All but one Janus kinase (JAK) inhibitor with dermatologic indications carries a black box warning that lists ...
It's called a "liver-chip." Researchers grew human liver cells on a small chip-like device, hoping to use it to predict ...
© Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical News Hubb All rights reserved.